Gould Capital »

Corcept Therapeutics Incorporated shares owned by Gould Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Gould Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $28k 600 46.28
2024-06-30 $20k 600 32.49
2024-03-31 $15k 600 25.19
2023-12-31 $16k 500 32.48
2023-09-30 $13k 500 26.29
2023-06-30 $11k 500 22.25
2023-03-31 $11k 500 21.66
2022-12-31 $10k 500 20.31
2022-09-30 $13k 500 26.00
2022-06-30 $12k 500 24.00
2022-03-31 $11k 500 22.00
2021-12-31 $10k 500 20.00

More positions owned by Gould Capital

Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total International Bond Etf Etf (BNDX)
Apple Stock (AAPL)
Spdr Gold Shares Etf (GLD)
Microsoft Corp Stock (MSFT)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Ishares Short Treasury Bond Etf Etf (SHV)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Public Storage Oper Reit (PSA)
Aflac Stock (AFL)
Bank New York Mellon Corp Stock (BK)
Aes Corp Stock (AES)
Coca Cola Stock (KO)

View all positions for Gould Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated